Citigroup Inc Nexalin Technology, Inc. Transaction History

Citigroup Inc

$153 Billion
Q2 2024

A detailed history of Citigroup Inc transactions in Nexalin Technology, Inc. stock. As of the latest transaction made, Citigroup Inc holds 1 shares of NXL stock, worth $2. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

% of portfolio

0.0%

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2024 Aug 12, 2024	BUY	$0.61 - $2.96 $0 - $2	1 New	1 $0

Others Institutions Holding NXL

# of Institutions

Shares Held

276K

Call Options Held

Put Options Held

Morgan Stanley New York, NY

59.8K
Shares

$175,228
0.0% of portfolio
Cvi Holdings, LLC Wilmington, DE

55.5K
Shares

$162,503
0.81% of portfolio
Geode Capital Management, LLC Boston, MA

44.1K
Shares

$129,101
0.0% of portfolio
Atria Wealth Solutions, Inc. New York, NY

38.4K
Shares

$112,550
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

31.8K
Shares

$93,115
0.0% of portfolio

View Full List

About Nexalin Technology, Inc.

Ticker NXL
Exchange
Sector Healthcare
Industry Medical Devices
Shares Outstandng 7,279,960
Market Cap $21.3M

More about NXL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account